ISID Home
about ISID | membership | programs | publications | resources | 14th ICID | site map
 
ProMed Home
 
  Navigation
Home
Subscribe/Unsubscribe
Search Archives
Announcements
Recalls/Alerts
Calendar of Events
Maps of Outbreaks
Submit Info
FAQs
Who's Who
Awards
Citing ProMED-mail
Links
Donations
About ProMED-mail
 
Archive Number 20090625.2312
Published Date 25-JUN-2009
Subject PRO/AH> Rabies, human - USA: vaccination protocol change

RABIES, HUMAN - USA: VACCINATION PROTOCOL CHANGE
*******************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Wed 24 Jun 2009
Source: The Boston Herald, Associated Press (AP) report [edited]
<http://www.bostonherald.com/news/national/general/view.bg?articleid=1181023>


Federal advisory panel: just 4 rabies shots needed
--------------------------------------------------
People exposed to rabies need only 4 vaccinations [for post-exposure 
prophylaxis - Mod.CP], not the 5 currently recommended, a vaccine 
advisory committee said Wednesday [24 Jun 2009]. In the past, rabies 
shots were dreaded almost as much as the disease itself. Until the 
1970s, an encounter with a rabid animal led to at least 14 shots in 
the abdomen. But vaccines have improved, and 5 shots in the arm or 
thigh have been the US standard for more than 20 years. The Advisory 
Committee on Immunization Practices voted unanimously that 4 shots -- 
all given within the 1st 14 days after exposure to rabies -- are 
sufficient. The panel advises the US Centers for Disease Control and 
Prevention, which issues official guidance to doctors.

Committee members made the decision after hearing that out of 20 000 
to 40 000 Americans exposed to rabies each year, an estimated 1000 
get only 3 or 4 shots and none of them have developed rabies. The 
shots cost between USD 100 and USD 200 apiece. Two companies make 
rabies vaccine for the US market, Novartis and Sanofi Pasteur.

The committee's recommendations usually harmonize with drug 
companies' package insert information about how their product should 
be used, but not in this case. A Novartis official, Clement Lewin, 
said he disagreed with the panel setting a precedent by making an 
off-label recommendation. He said it might confuse doctors who read 
company information about the vaccine that calls for 5 doses over 28 
days, but see government guidance that says 4 shots are enough.

Rabies is a viral disease transmitted through the bite of a rabid 
animal. Most rabies cases occur in wild animals like raccoons, 
skunks, bats, and foxes. The virus can infect the nervous system and 
can cause symptoms like insomnia, anxiety, confusion, paralysis, 
salivating, hallucinations, difficulty swallowing, and fear of water. 
Death usually occurs within days of the onset of symptoms. It's a 
recurring menace in the developing world, but the number of US deaths 
has declined to an average of 2 or 3 each year.

[Byline: Mike Stobbe]

--
Communicated by:
Powell Gammill
Health Professional, retired
Phoenix, AZ, USA
<pgammill@cox.net>

[The current regulations in the USA prior to implementation of this 
revision are detailed in the document entitled: Human Rabies 
Prevention -- United States, 2008, Recommendations of the Advisory 
Committee on Immunization Practices [ACIP], available at
<http://www.cdc.gov/mmwr/preview/mmwrhtml/rr57e507a1.htm#tab5>.

"ACIP recommends that prophylaxis for the prevention of rabies in 
humans exposed to rabies virus should include prompt and thorough 
wound cleansing followed by passive rabies immunization with human 
rabies immune globulin (HRIG) and vaccination with a cell culture 
rabies vaccine. For persons who have never been vaccinated against 
rabies, postexposure antirabies vaccination should always include 
administration of both passive antibody (HRIG) and vaccine (human 
diploid cell vaccine [HDCV] or purified chick embryo cell vaccine 
[PCECV]). Persons who have ever previously received complete 
vaccination regimens (pre-exposure or postexposure) with a cell 
culture vaccine or persons who have been vaccinated with other types 
of vaccines and have previously had a documented rabies virus 
neutralizing antibody titer should receive only 2 doses of vaccine: 
one on day 0 (as soon as the exposure is recognized and 
administration of vaccine can be arranged) and the 2nd on day 3. HRIG 
is administered only once (that is, at the beginning of antirabies 
prophylaxis) to previously unvaccinated persons to provide immediate, 
passive, rabies virus neutralizing antibody coverage until the 
patient responds to HDCV or PCECV by actively producing antibodies. A 
regimen of 5 [now 4] 1-mL doses of HDCV or PCECV should be 
administered intramuscularly to previously unvaccinated persons. The 
1st dose of the 5-dose [now 4-dose] course should be administered as 
soon as possible after exposure (day 0). Additional doses should then 
be administered on days 3, 7, 14, and 28 after the 1st vaccination. 
Rabies pre-exposure vaccination should include 3 1.0-mL injections of 
HDCV or PCECV administered intramuscularly (one injection per day on 
days 0, 7, and 21 or 28)."

Currently the 5-dose regime comprises vaccination at 3, 7, 14, and 28 
days after the primary vaccination. The proposed timing of the 4-dose 
regimen is not revealed in the press report. - Mod.CP]

[see also:
Rabies, canine, human - Indonesia (08): comment on vaccination 20090405.1317
Rabies, canine, human - Indonesia (07): comment on vaccination 20090404.1300]
...................................cp/mj/dk

*##########################################################*
************************************************************
ProMED-mail makes every effort to  verify  the reports  that
are  posted,  but  the  accuracy  and  completeness  of  the
information,   and  of  any  statements  or  opinions  based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by  ProMED-mail.   ISID
and  its  associated  service  providers  shall not be  held
responsible for errors or omissions or  held liable for  any
damages incurred as a result of use or reliance upon  posted
or archived material.
************************************************************
Become     a    ProMED-mail    Premium     Subscriber     at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************************
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send  all  items  for   posting  to:   promed@promedmail.org

(NOT to  an  individual moderator).  If you do not give your
full name and  affiliation, it  may  not  be  posted.   Send
commands  to  subscribe/unsubscribe,   get  archives,  help,
etc. to: majordomo@promedmail.org.    For assistance  from a
human  being  send  mail  to:   owner-promed@promedmail.org.

############################################################
############################################################

about ISID | membership | programs | publications | resources
14th ICID | site map | ISID home

©2001,2009 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.